Edition:
India

Evofem Biosciences Inc (EVFM.OQ)

EVFM.OQ on NASDAQ Stock Exchange Capital Market

2.52USD
17 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
12,047
52-wk High
$12.84
52-wk Low
$1.80

Latest Key Developments (Source: Significant Developments)

Evofem Biosciences Announces Pricing Of Public Offering Of Common Stock And Warrants
Tuesday, 22 May 2018 

May 22 (Reuters) - Evofem Biosciences Inc ::EVOFEM BIOSCIENCES ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK AND WARRANTS.EVOFEM BIOSCIENCES INC - SHARES AND PRE-FUNDED WARRANTS ARE BEING SOLD AT $4.69 PER SHARE AND $4.68 PER PRE-FUNDED WARRANT, RESPECTIVELY.  Full Article

Evofem Biosciences Files For Offering Up To 8 Million Shares Of Co's Stock
Wednesday, 16 May 2018 

May 16 (Reuters) - Evofem Biosciences Inc ::EVOFEM BIOSCIENCES FILES FOR OFFERING UP TO 8 MILLION SHARES OF CO'S STOCK, COMMON WARRANTS TO BUY AGGREGATE OF 1.6 MILLION SHARES OF CO'S COMMON STOCK.  Full Article

Evofem Biosciences Announces Proposed Public Offering Of Common Stock
Tuesday, 24 Apr 2018 

April 24 (Reuters) - Evofem Biosciences Inc ::EVOFEM BIOSCIENCES ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.EVOFEM BIOSCIENCES INC - LAUNCH OF AN UNDERWRITTEN PUBLIC OFFERING OF $40.0 MILLION OF ITS COMMON STOCK.  Full Article

Evofem Biosciences Files For Common Stock Offering Of Up To $57.5 Mln
Saturday, 7 Apr 2018 

April 6 (Reuters) - Evofem Biosciences Inc ::EVOFEM BIOSCIENCES FILES FOR COMMON STOCK OFFERING OF UP TO $57.5 MLN - SEC FILING.  Full Article

Neothetics to pay $1.5 mln‍​‍​ to Evofem Biosciences if deal terminated
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Neothetics Inc :Neothetics says if merger agreement with Evofem Biosciences terminated under specified circumstances, co to pay Evofem termination fee of up to $1.5 mln‍​‍​.  Full Article

Neothetics Inc and Evofem Biosciences Inc announce merger agreement to create Women’S health company
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Neothetics Inc :Neothetics Inc and Evofem Biosciences, Inc. announce merger agreement to create Women’S health company.Neothetics Inc - ‍privately-held Evofem Biosciences will merge with a wholly-owned subsidiary of Neothetics in an all-stock transaction​.Neothetics - ‍Invesco Asset Management entered securities purchase agreement to acquire additional $20 million of common stock in combined Co​.Neothetics Inc - ‍transactions have been approved by board of directors of both companies​.Neothetics - Neothetics will be renamed Evofem Biosciences and will be under leadership of Evofem Biosciences' CEO Saundra Pelletier​.Neothetics Inc - merger ‍exchange ratio assumes $171.4 million in value of Co's common stock will be issued to Evofem Biosciences stockholders in merger​.Neothetics - current Neothetics stockholders to own about 13% of combined company & current Evofem stockholders to own about 87% of combined company​.Neothetics Inc - ‍merger exchange ratio assumes $28.6 million in value of common stock being retained by Neothetics stockholders​.Neothetics Inc - ‍following merger, company will be led by Saundra Pelletier as chief executive officer​.  Full Article